Susvimo

Medicinal product

(Invented) name

Susvimo

Active substance (s)

Ranibizumabas

Strength

100 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA04, Ranibizumab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2026-09-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml injekcinio tirpalo yra:	1 ml
Ranibizumabas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122423	108535	1108535	flakonas	0,395 ml N1		Receptinis	EU/1/26/2058/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-09-18	Registruotas